logo
Menu

This search function provides links to outputs produced by NIHR Innovation Observatory. These are briefing notes or reports on new or repurposed technologies. This search will not return all technologies currently in development as these outputs are produced as required for our stakeholders.

Innovation Observatory > Reports > Devices > Monarch™ External Trigeminal Nerve Stimulation (eTNS) System for attention deficit hyperactive disorder (ADHD)

< Back

Monarch™ External Trigeminal Nerve Stimulation (eTNS) System for attention deficit hyperactive disorder (ADHD)

Devices

Mental Health, Drug Abuse and Learning Difficulties

March 2017


The Monarch™ external trigeminal nerve stimulation system (eTNS system) is a non-invasive device to treat attention deficit hyperactive disorder (ADHD) in children, young people and adults aged seven years and above. People with ADHD have behavioural symptoms including inattentiveness, hyperactivity and impulsiveness. Medicines used to treat ADHD have lots of side-effects and are only used in children and adults if other treatments fail.With the Monarch™ eTNS system, an electrical patch is applied onto the forehead and electrical impulses stimulate nerves in the brain. This can change the way the brain communicates messages. The patch is connected to an external pulse generator and the level of stimulation can be controlled by the patient. The device is used in the home at night whilst sleeping. This is the first non-invasive device approved for ADHD and the developer claims that it may work just as well as medication, but without the associated side effects.

Innovation Observatory Voice 0

Leave a Reply

Your email address will not be published. Required fields are marked *

Post Comment

PDF Report



 

Connect to the Innovation Observatory

Twitter

Load More Related Posts

Get Alerts